1 / 38

New ACLS Guidelines

salena
Download Presentation

New ACLS Guidelines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. New ACLS Guidelines LCDR Phil Colmenares MD MPH Emergency Medicine Department Portsmouth Naval Medical Center

    3. Relation of Collapse-to-CPR and Defibrillation to Survival

    4. ACLS

    5. ACLS Drugs/Algorithms

    6. ACLS Drugs/Algorithms ACS

    7. ACLS Drugs/Algorithms ACS Stroke

    8. ACLS Drugs/Algorithms ACS Stroke Electrolyte Abnormalities

    9. ACLS Drugs/Algorithms ACS Stroke Electrolyte Abnormalities Toxicology

    10. ACLS Drugs/Algorithms ACS Stroke Electrolyte Abnormalities Toxicology Environmental

    11. ACLS Drugs/Algorithms ACS Stroke Electrolyte Abnormalities Toxicology Environmental Asthma

    12. ACLS Drugs/Algorithms ACS Stroke Electrolyte Abnormalities Toxicology Environmental Asthma Anaphylaxis

    13. ACLS Drugs/Algorithms ACS Stroke Electrolyte Abnormalities Toxicology Environmental Asthma Anaphylaxis Trauma

    14. ACLS Drugs/Algorithms ACS Stroke Electrolyte Abnormalities Toxicology Environmental Asthma Anaphylaxis Trauma Pregnancy

    16. This is a schematic of the historical progression of the course from basic mouth-to-mouth and CPR to an evidence-based approach to resuscitative medicine. The fact is that although the new ACLS guidelines are a lot more evidence-based than the previous guidelines, a lot of the evidence is still kind of thin. But its getting betterThis is a schematic of the historical progression of the course from basic mouth-to-mouth and CPR to an evidence-based approach to resuscitative medicine. The fact is that although the new ACLS guidelines are a lot more evidence-based than the previous guidelines, a lot of the evidence is still kind of thin. But its getting better

    17. Linking AHA Evidence-Based Guidelines to ACLS Treatment Recommendations The AHA uses a number of categories to rank the evidenceThe AHA uses a number of categories to rank the evidence

    18. AHA Class Recommendations

    19. AHA Recommendations Class I As an example, does anyone remember what recommendation category epinephrine fell into under the old guidelines? (Class IIa) How about lidocaine? (Class IIa) How about high-dose epinephrine? (Class IIb) ----------------- Under the new guidelines regular epinephrine has gone from IIa to Class Indeterminate. Thats a big jump. And high-dose epinephrine has gone from IIb to Class Indeterminate. And lidocaine has gone from Class IIa to ???????? (Class Indeterminate). As an example, does anyone remember what recommendation category epinephrine fell into under the old guidelines? (Class IIa) How about lidocaine? (Class IIa) How about high-dose epinephrine? (Class IIb) ----------------- Under the new guidelines regular epinephrine has gone from IIa to Class Indeterminate. Thats a big jump. And high-dose epinephrine has gone from IIb to Class Indeterminate. And lidocaine has gone from Class IIa to ???????? (Class Indeterminate).

    20. Ventricular Fibrillation

    21. Ventricular Fibrillation

    22. High-Dose Epinephrine

    23. Standard-Dose Epinephrine (SDE) vs High-Dose Epinephrine (HDE) for Out-of-Hospital Cardiac Arrest

    24. High-Dose Epinephrine

    25. Vasopressin

    26. Epinephrine vs Vasopressin

    27. Epinephrine vs Vasopressin

    28. Epinephrine vs Vasopressin for Out-of-Hospital Cardiac Arrest

    29. Ventricular Fibrillation

    32. Magnesium for In-hospital Cardiac Arrest

    33. Magnesium in VF/VT Cardiac Arrest

    35. Procainamide in VF/VT Cardiac Arrest

    37. Lidocaine in Shock-refractory Out-of-Hospital VF This was the first controlled clinical study to evaluate the use of lidocaine in refractory VF. It was done in Tampa Bay, FL, and it used existing ACLS guidelines at the time, which included the use of intracardiac epinephrine. 116 patients were divided into a Lidocaine group and a No Lidocaine group. There 54 in the No Lidocaine group and 62 in the Lidocaine group. And as you can see there was no statistical difference in the amount or type of interventions used between the two groups except for the use of Lidocaine in one group and not the other. This was the first controlled clinical study to evaluate the use of lidocaine in refractory VF. It was done in Tampa Bay, FL, and it used existing ACLS guidelines at the time, which included the use of intracardiac epinephrine. 116 patients were divided into a Lidocaine group and a No Lidocaine group. There 54 in the No Lidocaine group and 62 in the Lidocaine group. And as you can see there was no statistical difference in the amount or type of interventions used between the two groups except for the use of Lidocaine in one group and not the other.

    38. Lidocaine in Shock-refractory Out-of-Hospital VF

    42. Ventricular Fibrillation

    43. Amiodarone

    44. Amiodarone 1962 - discovered in Belgium

    46. ARREST Trial: Design Objective Comparison of 1992 ACLS Guidelines with and without IV amiodarone in shock-refractory VT/VF cardiac arrest Methods Double-blind RCT (n=504) Randomization to 300 mg amiodarone or placebo Amiodarone dosing Rapid bolus of 300 mg vial diluted with D5W to a volume of 20 mL in sterile syringe

    48. Amiodarone for Cardiac Arrest: Benefit by Subgroups

    51. Amiodarone IV Hypotension 16.0 % Bradycardia 4.9 % Nausea 3.9 % LFT abnormalities 3.4 % Cardiac arrest 2.9 % VT 2.4 % CHF 2.1 % Fever 2.0 %

    52. Hypotension Rarely a cause for discontinuing the drug

    53. Amiodarone Begin with a 150 mg IV bolus over 10 min for a perfusing rhythm, and 300 mg IV bolus for cardiac arrest

    55. Tachycardia

    56. Estimating Cardiac Function

    57. Tachycardia

    58. Atrial Fibrillation / Atrial Flutter

    59. Atrial Fibrillation / Atrial Flutter There is now a much more detailed approach to atrial fibrillation and atrial flutter 1. Is cardiac function impaired? 2. Has a. fib or a. flutter been present for more or less than 48 hours? If the patient has WPW and cardiac function is impaired, then DC cardioversion or amiodarone is used to control the rate. There is now a much more detailed approach to atrial fibrillation and atrial flutter 1. Is cardiac function impaired? 2. Has a. fib or a. flutter been present for more or less than 48 hours? If the patient has WPW and cardiac function is impaired, then DC cardioversion or amiodarone is used to control the rate.

    60. Patient clinically unstable? Cardiac function impaired? WPW present? Duration < 48 or > 48 hours? 4 Clinical Features

    61. Treat unstable patients urgently Control the rate Convert the rhythm Provide anticoagulation Clinical Evaluation

    62. Tachycardia

    63. Tachycardia

    64. PSVT

    65. SVT

    66. Tachycardia

    67. Simplified SVT Algorithm

    68. Simplified SVT Algorithm

    69. Tachycardia

    70. Tachycardia

    71. Ventricular Tachycardia

    72. Ventricular Tachycardia Note that it is now acceptable to treat any type of stable VT immediately with cardioversion. Thats a significant change form the old algorithm.Note that it is now acceptable to treat any type of stable VT immediately with cardioversion. Thats a significant change form the old algorithm.

    73. Procainamide vs Lidocaine in Stable VT

    75. Tachycardia

    76. Tachycardia

    77. WCT of Unknown Type

    78. WCT of Unknown Type Note that adenosine has been removed from the WCT algorithm. It was removed because most WCT are VT, and it was decided that too much time is wasted using adenosine merely as a diagnostic tool rather than getting down to treating the WCT. Lidocaine and Bretylium are no longer recommended either. Procainamide is only indicated if cardiac function is preserved. If so, it is a IIa agent, as is amiodarone.Note that adenosine has been removed from the WCT algorithm. It was removed because most WCT are VT, and it was decided that too much time is wasted using adenosine merely as a diagnostic tool rather than getting down to treating the WCT. Lidocaine and Bretylium are no longer recommended either. Procainamide is only indicated if cardiac function is preserved. If so, it is a IIa agent, as is amiodarone.

    79. Wide-complex Tachycardia: Ineffectiveness of Lidocaine This is another study done in Illinois, and published in 1988 that should an unimpressive rate of efficacy for the use of lidocaine in refractory VF in 20 patients. However, its a small retrospective study so its hard to make strong conclusions based only on the results here. Nevertheless, it showed that among 20 patients with refractory WCT, 15 patients were totally unresponsive to lidocaine. 5 patients (4 with VT and 1 with SVT) converted to NSR within 15 minutes of having received lidocaine. To say that it was the lidocaine that converted them is a huge leap of faith for a number of reasons. First 3 of the 5 that converted to NSR had also received Verapamil. In addition, three of the patients that converted to NSR, ended up reverting to WCT, and none of these responded to Lidocaine. So even if you accept that the 2 patients that remained in NSR was due to the lidocaine (which is a big IF), the efficacy is really unimpressive. Of course, this is a retrospective study, its small, and there is no control group, but it suggests that lidocaine is not very good for refractory VF.This is another study done in Illinois, and published in 1988 that should an unimpressive rate of efficacy for the use of lidocaine in refractory VF in 20 patients. However, its a small retrospective study so its hard to make strong conclusions based only on the results here. Nevertheless, it showed that among 20 patients with refractory WCT, 15 patients were totally unresponsive to lidocaine. 5 patients (4 with VT and 1 with SVT) converted to NSR within 15 minutes of having received lidocaine. To say that it was the lidocaine that converted them is a huge leap of faith for a number of reasons. First 3 of the 5 that converted to NSR had also received Verapamil. In addition, three of the patients that converted to NSR, ended up reverting to WCT, and none of these responded to Lidocaine. So even if you accept that the 2 patients that remained in NSR was due to the lidocaine (which is a big IF), the efficacy is really unimpressive. Of course, this is a retrospective study, its small, and there is no control group, but it suggests that lidocaine is not very good for refractory VF.

    80. Tachyarrhythmic Agents

    81. Tachyarrhythmic Agents

    82. Tachyarrhythmic Agents

    83. Tachyarrhythmic Agents

    84. Tachyarrhythmic Agents

    85. Tachyarrhythmic Agents

    86. Other Minor Changes ETT Placement ETT Placement must now be confirmed by using nonphysical examination techniques like end-tidal CO2 detectors and esophageal detector devices. Prehospital EKGs are useful in urban/suburban EMS systems and should become standard equipment on all ACLS units. Isoproterenol has been removed from the bradycardia algorithm. The new PEA algorithm requires immediate assessment of blood flow with a doppler or direct ultrasound of the heart.ETT Placement must now be confirmed by using nonphysical examination techniques like end-tidal CO2 detectors and esophageal detector devices. Prehospital EKGs are useful in urban/suburban EMS systems and should become standard equipment on all ACLS units. Isoproterenol has been removed from the bradycardia algorithm. The new PEA algorithm requires immediate assessment of blood flow with a doppler or direct ultrasound of the heart.

    87. Summary

    88. Summary

    89. Summary

    95. Questions?

More Related